Karimi, F., & Arya, A. (2023). SGLT2 Inhibitor-Induced Ketonemia and Its Related Metabolic and Anti-Inflammatory Impacts in Adult Patients with Type 2 Diabetes: SGLT2 inhibitor-induced ketonemia in type 2 diabetes. Iranian Journal of Pharmaceutical Sciences, 19(2), 176–187. https://doi.org/10.22037/ijps.v19i2.42072